210 related articles for article (PubMed ID: 7689282)
1. Stability governs the apparent expression of "particulate" hepatitis B e antigen by mutant hepatitis B virus core particles.
Seifer M; Standring DN
Virology; 1993 Sep; 196(1):70-8. PubMed ID: 7689282
[TBL] [Abstract][Full Text] [Related]
2. Carboxy-terminal truncations of the HBV core protein affect capsid formation and the apparent size of encapsidated HBV RNA.
Beames B; Lanford RE
Virology; 1993 Jun; 194(2):597-607. PubMed ID: 7684872
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus capsid: localization of the putative immunodominant loop (residues 78 to 83) on the capsid surface, and implications for the distinction between c and e-antigens.
Conway JF; Cheng N; Zlotnick A; Stahl SJ; Wingfield PT; Belnap DM; Kanngiesser U; Noah M; Steven AC
J Mol Biol; 1998 Jun; 279(5):1111-21. PubMed ID: 9642088
[TBL] [Abstract][Full Text] [Related]
4. [Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology].
Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):680-5. PubMed ID: 15971579
[TBL] [Abstract][Full Text] [Related]
5. Comparative immunogenicity of hepatitis B virus core and E antigens.
Milich DR; McLachlan A; Stahl S; Wingfield P; Thornton GB; Hughes JL; Jones JE
J Immunol; 1988 Nov; 141(10):3617-24. PubMed ID: 2460543
[TBL] [Abstract][Full Text] [Related]
6. Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein.
Zlotnick A; Cheng N; Conway JF; Booy FP; Steven AC; Stahl SJ; Wingfield PT
Biochemistry; 1996 Jun; 35(23):7412-21. PubMed ID: 8652518
[TBL] [Abstract][Full Text] [Related]
7. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
8. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
[TBL] [Abstract][Full Text] [Related]
9. Assembly of physalis mottle virus capsid protein in Escherichia coli and the role of amino and carboxy termini in the formation of the icosahedral particles.
Sastri M; Kekuda R; Gopinath K; Kumar CT; Jagath JR; Savithri HS
J Mol Biol; 1997 Oct; 272(4):541-52. PubMed ID: 9325111
[TBL] [Abstract][Full Text] [Related]
10. [Synthesis of hepatitis B virus core antigen (HBcAg) particles by recombinant vaccinia virus].
Loparev VN; Araslanov RR; Mitina IV; Antonova TP; Ianova NN; Iashina TL; Chernos VI
Mol Gen Mikrobiol Virusol; 1990 Oct; (10):18-22. PubMed ID: 1702184
[No Abstract] [Full Text] [Related]
11. Phosphorylation of hepatitis B virus core C-terminally truncated protein (Cp149) by PKC increases capsid assembly and stability.
Kang H; Yu J; Jung G
Biochem J; 2008 Nov; 416(1):47-54. PubMed ID: 18605987
[TBL] [Abstract][Full Text] [Related]
12. Structural analysis of Sindbis virus capsid mutants involving assembly and catalysis.
Choi HK; Lee S; Zhang YP; McKinney BR; Wengler G; Rossmann MG; Kuhn RJ
J Mol Biol; 1996 Sep; 262(2):151-67. PubMed ID: 8831786
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus e antigen specific epitopes and limitations of commercial anti-HBe immunoassays.
Baumeister MA; Medina-Selby A; Coit D; Nguyen S; George-Nascimento C; Gyenes A; Valenzuela P; Kuo G; Chien DY
J Med Virol; 2000 Mar; 60(3):256-63. PubMed ID: 10630956
[TBL] [Abstract][Full Text] [Related]
14. Suitability of yeast- and Escherichia coli-expressed hepatitis B virus core antigen derivatives for detection of anti-HBc antibodies in human sera.
Li ZX; Hong GQ; Hu B; Liang MJ; Xu J; Li L
Protein Expr Purif; 2007 Dec; 56(2):293-300. PubMed ID: 17897838
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
[TBL] [Abstract][Full Text] [Related]
17. Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B.
Zhang X; Zoulim F; Habersetzer F; Xiong S; Trépo C
J Med Virol; 1996 Jan; 48(1):8-16. PubMed ID: 8825704
[TBL] [Abstract][Full Text] [Related]
18. [Construction and characterization of hepatitis B surface antigen "a" epitope virus-like particles].
Chen SY; Guo MZ; Qiu F; Fei YL; Yi Y; Guo Y; Jia ZY; Yu T; Bi SL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):30-2. PubMed ID: 20848844
[TBL] [Abstract][Full Text] [Related]
19. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
Shiau AL; Murray K
J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
[TBL] [Abstract][Full Text] [Related]
20. Structural comparisons of hepatitis B core antigen particles with different C-terminal lengths.
Liu S; He J; Shih C; Li K; Dai A; Zhou ZH; Zhang J
Virus Res; 2010 May; 149(2):241-4. PubMed ID: 20144668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
